Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co‐treated …

C Yang, C Sheng, G Liao, Y Su, L Feng… - Journal of Clinical …, 2021 - Wiley Online Library
What is known and objective Mycophenolate mofetil, an ester prodrug of mycophenolic acid
(MPA), is widely used to prevent graft rejection after kidney transplantation. The …
被引用次数：11 相关文章

Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co‐treated …

C Yang, C Sheng, G Liao, Y Su… - Journal of Clinical …, 2021 - search.ebscohost.com
What is known and objective: Mycophenolate mofetil, an ester prodrug of mycophenolic acid
(MPA), is widely used to prevent graft rejection after kidney transplantation. The …

Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co-treated …

CL Yang, CC Sheng, GY Liao, Y Su… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
What is known and objective Mycophenolate mofetil, an ester prodrug of mycophenolic acid
(MPA), is widely used to prevent graft rejection after kidney transplantation. The …

Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co-treated …

CL Yang, CC Sheng, GY Liao, Y Su… - Journal of Clinical …, 2021 - europepmc.org
Methods In total, 917 MPA and 740 MPAG concentrations in191 adult patients were
analysed via nonlinear mixed-effects modelling. The concentration-time data were …